RT Journal Article
SR Electronic
T1 Precision association of lymphatic disease spread with radiation-associated toxicity in oropharyngeal squamous carcinomas
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.25.20181867
DO 10.1101/2020.08.25.20181867
A1 Wentzel, Andrew
A1 Luciani, Timothy
A1 van Dijk, Lisanne V.
A1 Taku, Nicolette
A1 Elgohari, Baher
A1 Mohamed, Abdallah S. R.
A1 Canahuate, Guadalupe
A1 Fuller, Clifton D.
A1 Vock, David M.
A1 Marai, G. Elisabeta
YR 2020
UL http://medrxiv.org/content/early/2020/08/31/2020.08.25.20181867.abstract
AB Purpose Using a cohort of 582 head and neck cancer patients with nodal disease, we employed clustering over a novel graph-based geometrical representation of lymph node spread in order to identify groups of similar patients. We show that these groups are significantly correlated with radiation-associated dysphagia (RAD), and predictive of late aspiration and feeding tube toxicity.Materials and methods All patients received radiotherapy for oropharyngeal cancer (OPC) and had non-metastatic affected lymph nodes in the head and neck. Affected lymph nodes were segmented from pretreatment contrast-enhanced tomography scans and categorized according to consensus guidelines. Similar patients were clustered into 4 groups according to a graph-based representation of affected lymph nodes. Correlation between dysphagia associated symptoms and patient groups was calculated.Results Out of 582 patients, 26% (152) experienced toxicity during a follow up evaluation 6 months after completion of radiotherapy treatment. Patient groups identified by our approach were significantly correlated with dysphagia, feeding tube, and aspiration toxicity (p <.0005). Conclusion: Our work successfully stratified a patient cohort into similar groups using a structural geometry, graph-encoding of affected lymph nodes in OPC patients, that were predictive of late radiation-associated dysphagia. Our results suggest that structural geometry-aware characterization of affected lymph nodes can be used to better predict radiation-associated dysphagia at time of diagnosis, and better inform treatment guidelines.Competing Interest StatementThe authors have declared no competing interest.Funding StatementDr. van Dijk receives funding from the Nederlandse Organisatie voor Wetenschappelijk Onderzoek/Netherlands Research Organization Rubicon Award (452182317). Dr. Mohamed receives funding support from an MD Anderson Institutional Research Grant (IRG). Dr.s Canahuate, Fuller, Mohamed, Vock and Marai received/receive funding and salary support related to this project during the period of study execution from: the National Institutes of Health (NIH) Big Data to Knowledge (BD2K) Program of the National Cancer Institute (NCI) Early Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science Award (1R01CA2148250), and from the QuBBD program of the National Cancer Institute (R01CA225190); National Science Foundation (NSF), Division of Mathematical Sciences, Joint NIH/NSF Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) Grant (NSF 1557679). Drs. Fullerand Mohamed received/receive funding and salary support related to this project during the period of study execution from the NCI Early Phase Clinical Trials in Imaging and Image-Guided Interventions Program (1R01CA218148); an NIH/NCI Cancer Center Support Grant (CCSG) Pilot Research Program Award from the UT MD Anderson CCSG Radiation Oncology and Cancer Imaging Program (P30CA016672). Dr. Fuller and Mohamed received/receive funding and salary support unrelated to this project during the period of study execution from: the National Institute for Dental and Craniofacial Research Establishing Outcome Measures Award (1R01DE025248/R56DE025248) and Academic Industrial Partnership Grant (R01DE028290). Dr. Fuller received/receives additional funding and salary support unrelated to this project during the period of study execution from: National Institute of Biomedical Imaging and Bioengineering (NIBIB) Research Education Programs for Residents and Clinical Fellows Grant (R25EB025787-01); an NIH/NCI Head and Neck Specialized Programs of Research Excellence (SPORE) Developmental Research Program Award (P50 CA097007); NSF Division of Civil, Mechanical, and Manufacturing Innovation (CMMI) grant (NSF 1933369); and the Sabin Family Foundation. Direct infrastructure support for this project is provided to Dr. Fuller by the multidisciplinary Stiefel Oropharyngeal Research Fund of the University of Texas MD Anderson Cancer Center Charles and Daneen Stiefel Center for Head and Neck Cancer and the Cancer Center Support Grant (P30CA016672) and the MD Anderson Program in Image-guided Cancer Therapy. Dr. Fuller has received direct industry grant support, honoraria, and travel funding from Elekta AB unrelated to this project. Dr. Marai received/receives additional funding, travel funding, and salary support unrelated to this project during the period of study execution from the U.S. National Institutes of Health (NIH) National Library of Medicine (R01LM012527), from the U.S. National Science Foundation (NSF) through five other awards (CNS-1625941, CNS-1828265, CDS&E- 1854815, IIS-2031095, CBET-1854815), from the Discovery Partners Institute in Chicago, and from The Joseph and Bessie Feinberg Foundation. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:MD Anderson Human Research Protection ProgramAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are not available at this time.